Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: A randomized, controlled trial

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 10, 2008, Pages 3900-3906

  Mai, K ^a,b   Bobbert, T ^a,b   Reinecke, F ^a,b   Andres, J ^a,b   Maser Gluth, C ^d   Wudy, S A ^e   Mohlig M ^a,b   Weickert, M O ^a,b   Hartmann, M F ^e   Schulte, H M ^c   Diederich, S ^a,b,c   Pfeiffer, A F H ^a,b   Spranger, Joachim ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c Endokrinologikum Berlin   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ANDROSTENEDIONE; ESTRADIOL; ESTRONE; FATTY ACID; HEPARIN; LIPID; PRASTERONE; PRASTERONE ACETATE; PRASTERONE SULFATE; SODIUM CHLORIDE; TESTOSTERONE; TRIACYLGLYCEROL;

ANDROGEN BLOOD LEVEL; ANDROGEN METABOLISM; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HUMAN; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL; URINARY EXCRETION;

EID: 53749088733     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0714     Document Type: Article

References (33)

1. The Rotterdam ESHRE ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41-47
2. Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L 2003 Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism 52:908-915
3. Dunaif A, Segal KR, Futterweit W, Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174
4. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800
5. Holte J, Bergh T, Berne C, Lithell H 1994 Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Clin Endocrinol (Oxf) 41:463-471
6. Meirow D, Raz I, Yossepowitch O, Brzezinski A, Rosler A, Schenker JG, Berry EM 1996 Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies? Hum Reprod 11:1848-1853
7. Mai K, Bobbert T, Kullmann V, Andres J, Rochlitz H, Osterhoff M, Weickert MO, Bahr V, Mohlig M, Pfeiffer AF, Diederich S, Spranger J 2006 Free fatty acids increase androgen precursors in vivo. J Clin Endocrinol Metab 91:1501-1507
8. Boden G, Jadali F, White J, Liang Y, Mozzoli M, Chen X, Coleman E, Smith C1991 Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88:960-966
9. Muggeo M, Tiengo A, Fedele D, Crepaldi G 1975 The influence of plasma triglycerides on human growth hormone response to arginine and insulin: a study in hyperlipemics and normal subjects. Horm Metab Res 7:367-374
10. Lindholm M, Eklund JO, Hamberger B, Jarnberg PO 1984 Plasma catecholamine and free fatty acid levels during infusion of lipid emulsion in critically ill patients. Crit Care Med 12:953-956
11. Piatti PM, Monti LD, Baruffaldi L, Magni F, Paroni R, Fermo I, Costa S, Santambrogio G, Nasser R, Marchi M 1995 Effects of an acute increase in plasma triglyceride levels on glucose metabolism in man. Metabolism 44:883-889
12. Ferriman D, Gallwey JD 1961 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440-1447
13. Du BD, Du Bois EF 1989 A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 5:303-311
14. Pocock S 1984 Clinical trials. A practical approach. New York: John Wiley
15. Mai K, Bobbert T, Kullmann V, Andres J, Bahr V, Maser-Gluth C, Rochlitz H, Spranger J, Diederich S, Pfeiffer AF 2006 No effect of free fatty acids on adrenocorticotropin and cortisol secretion in healthy young men. Metabolism 55:1022-1028
16. Hammer F, Subtil S, Lux P, Maser-Gluth C, Stewart PM, Allolio B, Arlt W 2005 No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: in vivo and in vitro studies. J Clin Endocrinol Metab 90:3600-3605
17. Vecsei P, Akanbou C, Joumaah A, Sallum N 1972 Studies on antibodies against corticoid hormones. Acta Endocr (Copenh) 69(Suppl 159):33-45
18. Vecsei P 1978 [Radioimmunoassay]. Med Klin 73:497-507
19. Remer T, Boye KR, Hartmann MF, Wudy SA 2005 Urinary markers of adrenarche: reference values in healthy subjects, aged 3-18 years. J Clin Endocrinol Metab 90:2015-2021
20. Gooren L 2003 Testosterone supplementation: why and for whom? Aging Male 6:184-199
21. Arlt W, Haas J, Callies F, Reincke M, Hubler D, Oettel M, Ernst M, Schulte HM, Allolio B 1999 Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens. J Clin Endocrinol Metab 84:2170-2176
22. Arlt W, Justl HG, Callies F, Reincke M, Hubler D, Oettel M, Ernst M, Schulte HM, Allolio B 1998 Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 83:1928-1934
23. Simonsen S, Kjekshus JK 1978 The effect of free fatty acids on myocardial oxygen consumption during atrial pacing and catecholamine infusion in man. Circulation 58(3 Pt 1):484-491
24. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA 1983 Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72:1737-1747
25. Lewis GF, Vranic M, Harley P, Giacca A 1997 Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes 46:1111-1119
26. Carpentier A, Mittelman SD, Bergman RN, Giacca A, Lewis GF 2000 Prolonged elevation of plasma free fatty acids impairs pancreatic β-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes 49:399-408
27. Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghanim H, Aljada A, Dandona P 2003 Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 52:2882-2887
28. Remer T 2006 Free fatty acids and androgen precursors in vivo. J Clin Endocrinol Metab 23: (Letter)
29. Metcalf MG 1974 Effect of age, obesity, starvation, and changes in adrenocortical and ovarian activity on the urinary excretion of dehydroepiandrosterone relative to androsterone plus etiocholanolone: relevance to the measurement of breast cancer discriminants in women. Clin Biochem 7:119-130
30. Longcope C 1986 Adrenal and gonadal androgen secretion in normal females. Clin Endocrinol Metab 15:213-228
31. Wang C, Catlin DH, Starcevic B, Heber D, Ambler C, Berman N, Lucas G, Leung A, Schramm K, Lee PW, Hull L, Swerdloff RS 2005 Low-fat high-fiber diet decreased serum and urine androgens in men. J Clin Endocrinol Metab 90:3550-3559
32. De LB, Basdevant A, Thomas G, Thalabard JC, Mercier-Bodard C, Conard J, Guyene TT, Mairon N, Corvol P, Guy-Grand B 1986 Biological effects of estradiol-17β in postmenopausal women: oral versus percutaneous administration. J Clin Endocrinol Metab 62:536-541
33. Messinis IE, Milingos S, Alexandris E, Mademtzis I, Kollios G, Seferiadis K 2002 Evidence of differential control of FSH and LH responses to GnRH by ovarian steroids in the luteal phase of the cycle. Hum Reprod 17:299-303